Some 20 generic drugmakers accused of price-fixing their products must complete discovery and submit all relevant documents to federal court by Dec. 20, according to a pretrial order filed Oct. 24 in the U.S. District Court for the Eastern District of Pennsylvania.
Judge Cynthia M. Rufe’s order has significantly moved up the civil case’s timeline, ramping up pressure on the defendants, which include Teva Pharmaceuticals, Mylan Pharmaceuticals, Inc., and Sandoz, among others.
The companies face a lawsuit brought by 44 states that alleges industry-wide coordination to inflate prices, divvy up markets, and block competition. Potentially huge damages are at stake ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.